This article is more than 5 years old. Information may no longer be current.

B&L withdraws patent lawsuit over supplement

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ROCHESTER, N.Y. — Bausch & Lomb has dismissed a patent infringement lawsuit that the company filed last week against Inverness Medical Innovations and its wholly owned subsidiary IVC Industries.

The lawsuit, filed in the U.S. District Court in Rochester, alleged that Inverness and its subsidiary manufacture and distribute a vitamin supplement that infringes B&L’s rights to the formula of its Ocuvite PreserVision supplement.

According to a press release from B&L, the lawsuit is being dismissed without prejudice after written communications from Inverness made clear that Inverness does not manufacture or distribute the private-label eye vitamins in question.